CV Sciences, Inc. (OTCMKTS:CVSI) Short Interest Down 54.8% in October

CV Sciences, Inc. (OTCMKTS:CVSI) was the recipient of a significant decrease in short interest during the month of October. As of October 31st, there was short interest totalling 9,800 shares, a decrease of 54.8% from the October 15th total of 21,700 shares. Based on an average trading volume of 550,900 shares, the days-to-cover ratio is presently 0.0 days.

CV Sciences Price Performance

OTCMKTS:CVSI remained flat at $0.05 on Wednesday. 215,303 shares of the company traded hands, compared to its average volume of 279,435. CV Sciences has a fifty-two week low of $0.03 and a fifty-two week high of $0.10. The stock has a market cap of $8.42 million, a PE ratio of -4.56 and a beta of 0.59. The company’s 50 day moving average price is $0.05 and its 200 day moving average price is $0.05.

About CV Sciences

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.